326 related articles for article (PubMed ID: 4064843)
81. Abnormal DNA synthesis in polyamine deficient cells revealed by bromodeoxyuridine-flow cytometry technique.
Fredlund JO; Johansson M; Baldetorp B; Oredsson SM
Cell Prolif; 1994 May; 27(5):243-56. PubMed ID: 10465009
[TBL] [Abstract][Full Text] [Related]
82. Flow cytometric analysis of DNA ploidy and proliferative potential in brain tumours.
Gasińska A; Krzyszkowski T; Skołyszewski J; Biesaga B; Gliński B; Pyrich M
Folia Histochem Cytobiol; 1998; 36(3):133-8. PubMed ID: 9773297
[TBL] [Abstract][Full Text] [Related]
83. A rapid and simple estimation of cell cycle parameters by continuous labeling with bromodeoxyuridine.
Sasaki K; Murakami T; Takahashi M
Cytometry; 1987 Sep; 8(5):526-8. PubMed ID: 3311660
[TBL] [Abstract][Full Text] [Related]
84. A monoclonal antibody reactive with 5-bromo-2-deoxyuridine that does not require DNA denaturation.
Gonchoroff NJ; Greipp PR; Kyle RA; Katzmann JA
Cytometry; 1985 Nov; 6(6):506-12. PubMed ID: 3905299
[TBL] [Abstract][Full Text] [Related]
85. Simultaneous detection of fluorescent in situ hybridization and in vivo incorporated BrdU in a human bladder tumour.
Van Dekken H; Schervish EW; Pizzolo JG; Fair WR; Melamed MR
J Pathol; 1991 May; 164(1):17-22. PubMed ID: 2056386
[TBL] [Abstract][Full Text] [Related]
86. [Effect of adriamycin on cell cycle by bromodeoxyuridine-labeling method].
Tenjin T; Kimura T; Takeda H; Sakagami S; Takahashi N; Shoji T; Asano G
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3781-6. PubMed ID: 2596861
[TBL] [Abstract][Full Text] [Related]
87. Assessment of human tumour proliferation using bromodeoxyuridine--current status.
Wilson GD
Acta Oncol; 1991; 30(8):903-10. PubMed ID: 1777243
[TBL] [Abstract][Full Text] [Related]
88. In vitro bromodeoxyuridine-labelling of single cell suspensions: effects of time and temperature of sample storage.
Carbajo-Pérez E; Carbajo S; Ciudad J; López A; Dolbeare F; Orfao A
Cell Prolif; 1995 Nov; 28(11):609-15. PubMed ID: 8555373
[TBL] [Abstract][Full Text] [Related]
89. Thermal denaturation of DNA for immunochemical staining of incorporated bromodeoxyuridine (BrdUrd): critical factors that affect the amount of fluorescence and the shape of BrdUrd/DNA histogram.
Hoy CA; Seamer LC; Schimke RT
Cytometry; 1989 Nov; 10(6):718-25. PubMed ID: 2582962
[TBL] [Abstract][Full Text] [Related]
90. Comparison of S-phase fractions measured by flow cytometry and autoradiography in human transplant tumors.
Feichter G; Czech W; Haag D; Goerttler K; Futterman G; Loehrke H; Abel U
Cytometry; 1988 Nov; 9(6):605-11. PubMed ID: 3208626
[TBL] [Abstract][Full Text] [Related]
91. Intratumoral heterogeneity of S phase transition in solid tumours determined by bromodeoxyuridine labelling and flow cytometry.
Baisch H; Otto U
Cell Prolif; 1993 Sep; 26(5):439-48. PubMed ID: 9087534
[TBL] [Abstract][Full Text] [Related]
92. [Factors affecting 3H-thymidine incorporation into cells synthesizing DNA].
Kotel'nikov VM
Eksp Onkol; 1986; 8(6):9-15, 74. PubMed ID: 3542499
[TBL] [Abstract][Full Text] [Related]
93. Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67.
Parkins CS; Bush C; Price P; Steel GG
Cell Prolif; 1991 Mar; 24(2):171-9. PubMed ID: 2009320
[TBL] [Abstract][Full Text] [Related]
94. The applications of the BrdUrd-technique for the estimation of cycling S-phase cells in human renal cell carcinoma.
Langer EM; Hemmer J; Kleinhans G; Göhde W
Urol Res; 1988; 16(4):303-7. PubMed ID: 3176205
[TBL] [Abstract][Full Text] [Related]
95. Alterations in the DNA metabolism of MCa-11 mouse mammary tumor cells grown in vivo and in vitro.
Allison DC; Anderson S; Ridolpho PF; Meyne J; Robertson J
Cancer Res; 1986 Aug; 46(8):3951-7. PubMed ID: 3731066
[TBL] [Abstract][Full Text] [Related]
96. Comparison of different labelling index formulae used on bromodeoxyuridine-flow cytometry data.
Johansson MC; Johansson R; Baldetorp B; Oredsson SM
Cytometry; 1998 Jul; 32(3):233-40. PubMed ID: 9667513
[TBL] [Abstract][Full Text] [Related]
97. Variations in the [3H]thymidine labeling of S-phase cells in solid mouse tumors.
Allison DC; Ridolpho PF; Anderson S; Bose K
Cancer Res; 1985 Dec; 45(12 Pt 1):6010-6. PubMed ID: 4063961
[TBL] [Abstract][Full Text] [Related]
98. [Study of flow cytometric bromodeoxyuridine (BrdU)/DNA analysis using human solid tumors].
Shimabukuro T; Yamamoto M; Yoshihiro S; Matsuyama H; Yamamoto N; Sakatoku J
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):839-44. PubMed ID: 2496669
[TBL] [Abstract][Full Text] [Related]
99. Comparison of Vindelov et al. and bromodeoxyuridine/DNA double-staining flow cytometry methods for analysis of cell cycle distribution in rat thymocytes.
Orfao A; Carbajo S; Dolbeare F; Ciudad J; Lopez A; Carbajo-Perez E
Cytometry; 1996 Sep; 25(1):104-8. PubMed ID: 8875060
[TBL] [Abstract][Full Text] [Related]
100. In vitro bromodeoxyuridine labeling of malignant neoplasms. A comparative study with flow cytometry cell-cycle analysis.
Lloveras B; Garin-Chesa P; Myc A; Melamed M
Am J Clin Pathol; 1994 Jun; 101(6):703-7. PubMed ID: 8209855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
